Effects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells

Histology and Histopathology

Volumn 18, Issue 2, 2003, Pages 379-385

  Pérez Tomás, Ricardo ^a   Montaner, B ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Cell proliferation; Chemotherapy; Immunosuppressor; Prodigiosin

Indexed keywords

ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA FRAGMENT; PRODIGIOSIN; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; DRUG USE; ENZYME ASSAY; ENZYME INDUCTION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULE; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

APOPTOSIS; BENZIMIDAZOLES; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL DIVISION; COLORING AGENTS; CYCLIN-DEPENDENT KINASES; DNA FRAGMENTATION; FLUORESCENT DYES; HUMANS; JURKAT CELLS; PRECIPITIN TESTS; PRODIGIOSIN; RETINOBLASTOMA PROTEIN; THYMIDINE;

SERRATIA MARCESCENS;

EID: 0037378019     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Azuma T., Watanabe N., Yagisawa H., Hirata H., Iwamura M. and Kobayashi Y. (2000). Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel immunosuppressant. Immunopharmacology 46, 29-37.
2. Cameron R. and Feuer G. (2000). Molecular cellular and tissue reactions of apoptosis and their modulation by drugs. In: Apoptosis and Its Modulation by Drugs. 1 Ed. Cameron R. and Feuer G (eds). Springer Verlag. Berlin. Berlin . pp 37-57.
3. Díaz-Ruíz C., Montaner B. and Pérez - Tomás R. (2001). Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-1. Histol. Histopathol. 16, 415-421.
4. Han S.B., Kim H.M., Kim Y.H., Lee C.W., Jang E.S., Son K.H., Kim S.U. and Kim Y.K. (1998). T-cell specific immunosuppression by prodigiosin isolated from Serratia marcescens. Int. J. Immunopharmacol. 20, 1-13.
5. Hildebrand A., Pohl M. and Bhakdi S. (1991). Staphylococcus aureus α-toxin: Dual mechanisms of binding to target cells. J. Biol. Chem. 17195-17200.
6. Hiromura K., Pippin J.W., Fero M.L., Roberts J.M. and Shankland S.J. (1999). Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J. Clin. Invest. 103, 597-604.
7. Jonas D., Schultheis B., Klas C., Krammer P.H. and Bhakdi S. (1993). Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes. Infect. Immun. 61, 1715-1721.
8. Kawauchi K., Shibutani K., Yagisawa H., Kamata H., Nakatsuji S., Anzai H., Yokoyama Y., Ikegami Y., Moriyama Y. and Hirata H. (1997). A possible immunosuppressant, cycloprodigiosin hydrochloride, obtained from Pseudoalteromonas denitrificans. Biochem. Biophys. Res. Commun. 237, 543-547.
9. Kintscher U., Wakino S., Kim S., Jackson S.M., Fleck E., Hsueh W.A. and Law R.E. (2000). Doxazosin inhibits retinoblastoma protein phosphorylation and G1-S transition in human coronary smooth muscle cells. Arterioscl. Thromb. Vas. Biol. 20, 1216-1224.
10. Kochi S. and Collier R. (1993). DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp. Cell. Res. 208, 296-302.
11. + mature cytotoxic T cells by inhibitors of acidification of intracellular organelles, prodigiosin 25-C and concanamycin B. Immunology 99, 243-248.
12. Levkau B., Koyama H., Raines E.W., Clurman B.E., Herren B., Orth K., Roberts J.M. and Ross R. (1998). Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade. Mol. Cell. 1, 553-563.
13. Lowe S.W., Ruley H.E., Jacks T. and Housman D.E. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967.
14. Mangan D.F., Taichman N.S., Lally E.T. and Wahl S.M. (1991). Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect. Immun. 56, 3267-3272.
15. Melvin M., Tomlinson J., Saluta G., Kucera G., LIindquist N. and Manderville R. (2000). Double-strand DNA cleavage be cooperprodigiosin. J. Am. Chem. Soc. 122, 6333-6334.
16. Mgbonyebi OP., Russo J. and Russo I.J. (1999). Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Res. 59, 1903-1910.
17. Montaner B. and Pérez-Tomás R. (2001). Prodigiosin-induced apoptosis in human colon cancer cells. Life Sci. 68, 2025-2036.
18. Montaner B. and Pérez-Tomás R. (2002a). Activation of protein kinase C for protection of cells against apoptosis induced by the immunosuppressor prodigiosin. Biochem. Pharmacol. 63, 463-469.
19. Montaner B. and Pérez-Tomás R. (2002b). The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNK. Toxicol. Lett. 129, 93-98.
20. Montaner B., Navarro S., Piqué M., Vilaseca M., Martinell M., Giralt E., Gil J. and Pérez-Tomás R. (2000). Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoiteic cancer cell lines. Br. J. Pharmacol. 131, 585-593.
21. Morimoto H. and Bonavida B. (1992). Diphtheria toxin and pseudomonas A toxin mediated apoptosis. J. Immunol. 149, 289-2094.
22. Mortellaro A., Songia S., Gnocchi P., Ferrari M., Fornasiero C., D'Alessio R., Isetta A., Colotta F. and Golay J. (1999). New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation. J. Immunol. 162, 7102-7109.
23. Songia S., Mortellaro A., Taverna S., Fornasiero C., Scheiber E., Erba E., Colotta F., Mantovani A., Isetta A. and Golay J. (1997). Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes. J. Immunol. 158, 3987-3995.
24. Tsuji R. F., Magae J., Jamashita M., Nagai K. and Yamasaki M. (1992). Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses of cytotoxic T cells. J. Antibiot. 45, 1295-1302.
25. - symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice. Hepatology 30, 894-902.
26. - symporter, induces apoptosis in human breast cancer cell lines. J. Cancer Res. Clin. Oncol. 126, 191-197.
27. - symporter, induces apoptosis and differentiation in HL-60 cells. Int. J. Cancer 88, 121-128.
28. Zychlinsky A. and Santonetti P. (1997). Apoptosis in bacterial pathogenesis. J. Clin. Invest. 100, S63-S65.